Metodi biomolecolari per il follow up dei pazienti HIV positivi

As proviral human immunodeficiency virus type 1 (HIV-1) DNA can replenish and revive viral infection upon attivation, its analysis, in addition to RNA viral load, could be considered a useful marker during the follow-up of infected individuals, to evaluate reservoir status, especially in HAART-treat...

Full description

Bibliographic Details
Main Author: Schiavone, Pasqua <1971>
Other Authors: Re, Maria Carla
Format: Doctoral Thesis
Language:it
Published: Alma Mater Studiorum - Università di Bologna 2011
Subjects:
Online Access:http://amsdottorato.unibo.it/3449/
id ndltd-unibo.it-oai-amsdottorato.cib.unibo.it-3449
record_format oai_dc
spelling ndltd-unibo.it-oai-amsdottorato.cib.unibo.it-34492014-03-24T16:29:08Z Metodi biomolecolari per il follow up dei pazienti HIV positivi Schiavone, Pasqua <1971> MED/07 Microbiologia e microbiologia clinica As proviral human immunodeficiency virus type 1 (HIV-1) DNA can replenish and revive viral infection upon attivation, its analysis, in addition to RNA viral load, could be considered a useful marker during the follow-up of infected individuals, to evaluate reservoir status, especially in HAART-treated patients when RNA viral load is undetectable by current techniques and the antiretroviral efficacy of new, more potent therapeutic regimens. Standardized methods for the measurement of the two most significant forms of proviral DNA, total and non-integrated, are currently lacking, despite the widespread of molecular biology techniques. In this study, total and 2-LTR HIV-1 DNA proviral load, in addition to RNA viral load, CD4 cell count and serological parameters, were determined by quantitative analysis in peripheral blood mononuclear cells (PBMC) in naïve or subsequently HAART-treated patients with acute HIV-1 infection in order to establish the role of these two DNA proviral forms in the course of HIV infection. The study demonstrated that HAART-treated individuals show a significant decrease in both total and 2-LTR circular HIV-1 DNA proviral load compared with naïve patients: these findings confirm that HIV-1 reservoir decay correlates with therapeutic effectiveness. The persistence of small amounts of 2-LTR HIV-1 DNA form, which is considered to be a molecular determinant of infectivity, in PBMC from some patients demonstrates that a small rate of replication is retained even when HAART is substantially effective: HAART could not eradicate completely the infection because HIV is able to replicate at low levels. Plasma-based viral RNA assays may fail to demonstrate the full extent of viral activity. In conclusion, the availability of a new standardized assay to determine DNA proviral load will be important in assessing the true extent of virological suppression suggesting that its quantification may be an important parameter in monitoring HIV infection. Alma Mater Studiorum - Università di Bologna Re, Maria Carla 2011-05-02 Doctoral Thesis PeerReviewed application/pdf it http://amsdottorato.unibo.it/3449/ info:eu-repo/semantics/restrictedAccess
collection NDLTD
language it
format Doctoral Thesis
sources NDLTD
topic MED/07 Microbiologia e microbiologia clinica
spellingShingle MED/07 Microbiologia e microbiologia clinica
Schiavone, Pasqua <1971>
Metodi biomolecolari per il follow up dei pazienti HIV positivi
description As proviral human immunodeficiency virus type 1 (HIV-1) DNA can replenish and revive viral infection upon attivation, its analysis, in addition to RNA viral load, could be considered a useful marker during the follow-up of infected individuals, to evaluate reservoir status, especially in HAART-treated patients when RNA viral load is undetectable by current techniques and the antiretroviral efficacy of new, more potent therapeutic regimens. Standardized methods for the measurement of the two most significant forms of proviral DNA, total and non-integrated, are currently lacking, despite the widespread of molecular biology techniques. In this study, total and 2-LTR HIV-1 DNA proviral load, in addition to RNA viral load, CD4 cell count and serological parameters, were determined by quantitative analysis in peripheral blood mononuclear cells (PBMC) in naïve or subsequently HAART-treated patients with acute HIV-1 infection in order to establish the role of these two DNA proviral forms in the course of HIV infection. The study demonstrated that HAART-treated individuals show a significant decrease in both total and 2-LTR circular HIV-1 DNA proviral load compared with naïve patients: these findings confirm that HIV-1 reservoir decay correlates with therapeutic effectiveness. The persistence of small amounts of 2-LTR HIV-1 DNA form, which is considered to be a molecular determinant of infectivity, in PBMC from some patients demonstrates that a small rate of replication is retained even when HAART is substantially effective: HAART could not eradicate completely the infection because HIV is able to replicate at low levels. Plasma-based viral RNA assays may fail to demonstrate the full extent of viral activity. In conclusion, the availability of a new standardized assay to determine DNA proviral load will be important in assessing the true extent of virological suppression suggesting that its quantification may be an important parameter in monitoring HIV infection.
author2 Re, Maria Carla
author_facet Re, Maria Carla
Schiavone, Pasqua <1971>
author Schiavone, Pasqua <1971>
author_sort Schiavone, Pasqua <1971>
title Metodi biomolecolari per il follow up dei pazienti HIV positivi
title_short Metodi biomolecolari per il follow up dei pazienti HIV positivi
title_full Metodi biomolecolari per il follow up dei pazienti HIV positivi
title_fullStr Metodi biomolecolari per il follow up dei pazienti HIV positivi
title_full_unstemmed Metodi biomolecolari per il follow up dei pazienti HIV positivi
title_sort metodi biomolecolari per il follow up dei pazienti hiv positivi
publisher Alma Mater Studiorum - Università di Bologna
publishDate 2011
url http://amsdottorato.unibo.it/3449/
work_keys_str_mv AT schiavonepasqua1971 metodibiomolecolariperilfollowupdeipazientihivpositivi
_version_ 1716654335515951104